Bioorganic and Medicinal Chemistry Letters p. 1358 - 1361 (2006)
Update date:2022-08-03
Topics:
Ok, Dong
Li, Chunshi
Abbadie, Catherine
Felix, John P.
Fisher, Michael H.
Garcia, Maria L.
Kaczorowski, Gregory J.
Lyons, Kathryn A.
Martin, William J.
Priest, Birgit T.
Smith, McHardy M.
Williams, Brande S.
Wyvratt, Matthew J.
Parsons, William H.
Novel cyclopentane-based 3-phenyl-1-hydroxypropyl compounds were evaluated for inhibitory activity against the peripheral nerve sodium channel Na V1.7 and off-target activity against the cardiac potassium channel hERG. The stereochemistry of the hydroxyl group and substitution on the phenyl rings with either fluorinated O-alkyl or alkyl groups were found to be critical for conferring potency against NaV1.7. A benchmark compound from this series displayed efficacy in rat models of inflammatory and neuropathic pain.
View MoreChengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Suzhou Wedo Chemicals Co., Ltd.
Contact:86 512 58100425
Address:Zonger Road, DongSha Industry Park , Zhangjiagang, Jiangsu, China
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Suzhou Sibian Chemical Technology Co., Ltd
website:http://www.sibianpharm.com
Contact:+8618169181984,+8618013186906
Address:Room1404,BuildingA,Jiabao Square No.323 Baodai East Road,Wuzhong District,Suzhou Jiangsu China (215128)
Doi:10.1007/s10593-005-0281-6
(2005)Doi:10.1016/S0957-4166(03)00129-0
(2003)Doi:10.1021/acs.jmedchem.9b00147
(2019)Doi:10.1016/S0040-4039(00)87437-7
(1982)Doi:10.1021/jo0525027
(2006)Doi:10.1016/S0040-4020(01)90409-0
(1994)